Thursday - April 25, 2024

Chronic Refractory Cough Market Report 2032: Epidemiology Data, Pipeline Therapies, Latest FDA, EMA, PDMA Approvals by DelveInsight | Nerre Therapeutics, Avalo Therapeutics, Bellus Health, Genentech

The Chronic Refractory Cough Market size was valued USD 8,7845 Million in 2022 and the report offers an in-depth understanding of the Chronic Refractory Cough, historical and forecasted epidemiology as well as the Chronic Refractory Cough market trends in the … Continue reading

Pediatric Growth Hormone Deficiency Market and Epidemiology Forecast 2032: Population Data, Drugs, Companies and Competitive Intelligence by DelveInsight | OPKO Health, Lumos Pharma, Versartis Inc.

The Pediatric Growth Hormone Deficiency Market Forecast report offers an in-depth understanding of the Pediatric Growth Hormone Deficiency, historical and forecasted epidemiology as well as the Pediatric Growth Hormone Deficiency market trends in the 7MM. The Pediatric Growth Hormone Deficiency … Continue reading

Endometriosis Market is Predicted to Exhibit Remarkable Growth During the Forecast Period (2024-2034), Analyzes DelveInsight | Enteris BioPharma, Spago Nanomedical, Iqvia Pty, Myovant Sciences, others

The Endometriosis Market Insights, Epidemiology, and Market Forecast-2032″ report offers an in-depth understanding of the Endometriosis, historical and forecasted epidemiology as well as the Endometriosis market trends in the 7MM. DelveInsight’s “Endometriosis Market Insights, Epidemiology, and Market Forecast-2032″ report offers … Continue reading

Obesity Market and Epidemiology 2034: Treatment Market, Therapies, Companies, FDA Approvals, Epidemiology and Forecast by DelveInsight | D&D Pharmatech, ProQR Therapeutics, Nano Precision Medical

The Obesity Market size in the United States was projected to be around USD 2,000 million in 2023 and the report offers an in-depth understanding of the Obesity, historical and forecasted epidemiology as well as the Obesity market trends in … Continue reading

Pulmonary Arterial Hypertension Market to Register Incremental Growth During the Forecast Period (2023-2032), Asserts DelveInsight | Novartis, Insmed Inc, Chugai Pharma, Merck Sharp & Dohme, Janssen

The Pulmonary Arterial Hypertension Market size was valued approximately USD 4,838 million in 2022 and the report offers an in-depth understanding of the Pulmonary Arterial Hypertension, historical and forecasted epidemiology as well as the Pulmonary Arterial Hypertension market trends in … Continue reading

Invasive Aspergillosis Market is Expected to Expand at a Healthy Growth Rate During the Forecast Period (2023-2032), States DelveInsight | Pulmocide, F2G Biotech GmbH, Scynexis, Biosergen, CSPC Ouyi

The Invasive Aspergillosis Market Forecast report offers an in-depth understanding of the Invasive Aspergillosis, historical and forecasted epidemiology as well as the Invasive Aspergillosis market trends in the 7MM. DelveInsight’s “Invasive Aspergillosis Market Insights, Epidemiology, and Market Forecast-2032″ report offers … Continue reading

Primary Sclerosing Cholangitis Pipeline Drugs Analysis Report, 2024 Updates: FDA Approvals, Clinical Trials, Therapies, MOA, ROA by DelveInsight | Engitix, GRI Bio, Qing Bile Therapeutics, Sirnaomics

(Las Vegas, Nevada, United States) As per DelveInsight’s assessment, globally, Primary Sclerosing Cholangitis pipeline constitutes 14+ key companies continuously working towards developing 14+ Primary Sclerosing Cholangitis treatment therapies, analysis of Clinical Trials, Therapies, Mechanism of Action, Route of Administration, and … Continue reading

Cutaneous T-Cell Lymphoma (CTCL) Market Size was USD 520 million in 2023, estimates DelveInsight | 4SC, Bio-Path Holdings, BioInvent International, Bioniz Therapeutics, Citius Pharmaceuticals, Roche

Cutaneous T-Cell Lymphoma Market Cutaneous T-Cell Lymphoma (CTCL) Companies are 4SC, Bio-Path Holdings, BioInvent International AB, Bioniz Therapeutics, Citius Pharmaceuticals, Codiak BioSciences, Elorac, Equillium, Genzada Pharmaceuticals, Hoffmann-La Roche, Innate Pharma, Jiangsu Simcere Pharmaceutical, Kymera Therapeutics, Legend Biotech, Merck Sharp & … Continue reading